Delivery Order SPE2DB22D3016-SPE2DB25FAWY3

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a ceiling value of $1,390.52 and a completion date of March 6, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, with a ceiling value of $1,700.28 and a completion date of May 21, 2025. The contract is not set-aside and is awarded as part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has a ceiling value of $1,200.80 and an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has a ceiling value of $1,733.65 and is a firm fixed-price delivery order, with an ultimate completion date of April 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a ceiling value of $1,257.60 and a performance period through May 7, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a ceiling value of $1,372.02 and a completion date of May 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract is a firm fixed-price delivery order with a ceiling value of $2,133.88 and an ultimate completion date of August 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with an ultimate completion date of January 15, 2025 and a ceiling value of $5,686.02. The contract is a firm fixed price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a ceiling value of $4,049.72 and a period of performance through May 6, 2025. The contract is not set aside and was awarded on May 5, 2025. Amerisourcebergen Drug Corp is a large, for-profit company that serves as a critical supplier of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with an award value of $1,079.10 and a completion date of August 21, 2024. The contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen holds a larger indefinite delivery contract (IDC) with the DLA Troop...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAWY3
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a ceiling value of $1,080.48 and a completion date of May 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for federal agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.

Generated 8/24/25, 12:59 AM